Literature DB >> 15265982

Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells.

James Reed1, Christine McNamee, Stephen Rackstraw, John Jenkins, Diana Moss.   

Abstract

IgLONs are a family of four cell adhesion molecules belonging to the Ig superfamily that are thought to play a role in cell-cell recognition and growth-cone migration. One member of the family, opioid-binding cell-adhesion molecule (OBCAM), might act as a tumour suppressor. Previous work has shown that limbic-system-associated protein (LAMP), CEPU-1/Neurotrimin and OBCAM interact homophilically and heterophilically within the family. Here, we show that, based on their relative affinities, CEPU-1 might be both a homo- and a heterophilic cell adhesion molecule, whereas LAMP and OBCAM act only as heterophilic cell adhesion molecules. A binding assay using recombinant IgLONs fused to human Fc showed that IgLONs are organized in the plane of the membrane as heterodimers, and we propose that IgLONs function predominantly as subunits of heterodimeric proteins (Diglons). Thus, the four IgLONs can form six Diglons. Furthermore, although singly transfected cell lines have little effect on neurite outgrowth, CHO cell lines expressing both CEPU-1 and OBCAM (Diglon-CO) inhibit neurite outgrowth from cerebellar granule cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265982     DOI: 10.1242/jcs.01261

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  21 in total

1.  Large-scale screening for novel low-affinity extracellular protein interactions.

Authors:  K Mark Bushell; Christian Söllner; Benjamin Schuster-Boeckler; Alex Bateman; Gavin J Wright
Journal:  Genome Res       Date:  2008-02-22       Impact factor: 9.043

2.  IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth.

Authors:  Ricardo Sanz; Gino B Ferraro; Alyson E Fournier
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

3.  Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Grant C Sellar
Journal:  Reproduction       Date:  2009-01-27       Impact factor: 3.906

4.  Cell type- and brain region-resolved mouse brain proteome.

Authors:  Kirti Sharma; Sebastian Schmitt; Caroline G Bergner; Stefka Tyanova; Nirmal Kannaiyan; Natalia Manrique-Hoyos; Karina Kongi; Ludovico Cantuti; Uwe-Karsten Hanisch; Mari-Anne Philips; Moritz J Rossner; Matthias Mann; Mikael Simons
Journal:  Nat Neurosci       Date:  2015-11-02       Impact factor: 24.884

Review 5.  Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.

Authors:  Jane Antony; Elisa Zanini; James R Birtley; Hani Gabra; Chiara Recchi
Journal:  Cancer Gene Ther       Date:  2020-06-29       Impact factor: 5.987

6.  Construction of a large extracellular protein interaction network and its resolution by spatiotemporal expression profiling.

Authors:  Stephen Martin; Christian Söllner; Varodom Charoensawan; Boris Adryan; Bernard Thisse; Christine Thisse; Sarah Teichmann; Gavin J Wright
Journal:  Mol Cell Proteomics       Date:  2010-08-27       Impact factor: 5.911

7.  Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients.

Authors:  Karina Karis; Kattri-Liis Eskla; Maria Kaare; Karin Täht; Jana Tuusov; Tanel Visnapuu; Jürgen Innos; Mohan Jayaram; Tõnis Timmusk; Cynthia S Weickert; Marika Väli; Eero Vasar; Mari-Anne Philips
Journal:  Front Mol Neurosci       Date:  2018-01-29       Impact factor: 5.639

8.  OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.

Authors:  Yan Cui; Ying Ying; Andrew van Hasselt; Ka Man Ng; Jun Yu; Qian Zhang; Jie Jin; Dingxie Liu; Johng S Rhim; Sun Young Rha; Myriam Loyo; Anthony T C Chan; Gopesh Srivastava; George S W Tsao; Grant C Sellar; Joseph J Y Sung; David Sidransky; Qian Tao
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

9.  Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.

Authors:  Tale Barøy; Stine H Kresse; Magne Skårn; Marianne Stabell; Russell Castro; Silje Lauvrak; Antonio Llombart-Bosch; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  Mol Cancer       Date:  2014-04-28       Impact factor: 27.401

10.  Newly Identified Cancer-Associated Role of Human Neuronal Growth Regulator 1 (NEGR1).

Authors:  Hyejin Kim; Ji-Sook Hwang; Bogman Lee; Jinpyo Hong; Soojin Lee
Journal:  J Cancer       Date:  2014-07-21       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.